BIOTECHNOLOGY VALUE FUND L P - 12 Feb 2026 SCHEDULE 13D Report for IMMUNIC, INC. Common Stock, $0.0001 par value (IMUX)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
IMMUNIC, INC. Common Stock, $0.0001 par value
Symbol
IMUX
Shares outstanding
136,442,452 shares
Disclosed Ownership
13,630,601 shares
Ownership
10%
Form type
SCHEDULE 13D
Filing time
20 Feb 2026, 18:59:39 UTC
Date of event
12 Feb 2026
Previous filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (11)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 7.4% 10,113,585 0 10,113,585 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0000918923
BVF I GP LLC 7.4% 10,113,585 0 10,113,585 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803805
BIOTECHNOLOGY VALUE FUND II LP 2.2% 3,027,105 0 3,027,105 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001102444
BVF II GP LLC 2.2% 3,027,105 0 3,027,105 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803806
Biotechnology Value Trading Fund OS LP 0.3% 427,629 0 427,629 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660683
BVF Partners OS Ltd. 0.3% 427,629 0 427,629 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660684
BVF GP HOLDINGS LLC 9.6% 13,140,690 0 13,140,690 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803809
BVF PARTNERS L P/IL 10% 13,630,601 0 13,630,601 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001055947
BVF INC/IL 10% 13,630,601 0 13,630,601 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001056807
LAMPERT MARK N 10% 13,630,601 0 13,630,601 /s/ Mark N. Lampert Mark N. Lampert 0001233840
R. Thorvald Nagel 0% 0 0 0 /s/ R. Thorvald Nagel R. Thorvald Nagel